期刊文献+

血管活性物质测定在心血管疾病中的意义 被引量:2

Significance of Vasoactive Substances Levels Determination in Patient with Angiocardiopathy
下载PDF
导出
摘要 目的 :检测原发性高血压 (EH)和冠心病 (CHD)患者血中CNP、NO、CGRP、ET的含量 ,探讨其与内皮细胞功能的关系及临床意义。方法 :EH组 30例、CHD组 33例、正常对照组 30例 ,均为男性。CNP、CGRP、ET采用放射免疫分析法测定 ,NO采用生化比色镉还原法测定。结果 :EH和CHD组分别与对照组比较CNP、ET含量明显增高 (CNP :P <0 .0 1,ET :P <0 .0 5 ) ,NO、CGRP则明显降低 (P <0 .0 1) ;相关分析表明 :两组患者CNP与CGRP之间具有显著负相关性 (EH组r=0 .5 6 7,P <0 .0 1、CHD组r =0 .42 8,P <0 .0 5 )。结论 :检测EH和CHD血中CNP、NO、CGRP、ET含量变化 ,为研究EH ,CHD与内皮细胞功能关系、发病机理等提供了有价值的实验室依据。 Objective The serum contents of CNP?NO?CGRP and ET in patients with essential hypertension (EH) and coronary heart disease (CHD) were measured to study the relationship between those substances levels and the function of endothelial cell and its clinical significance. Method Blood speciman were from 30 patients with EH? 33 with CHD and 30 controls (all male). CNP?CGRP and ET were determined by RIA, NO was determined by biochemical cadmium reduction method. Results Compares with those in controls, the contents of CNP and ET increased significantly ( P <0.01, P <0.05, respectively), while the contents of NO?CGRP decreased ( P <0.01) significantly in EH and CHD Patients, correlation analysis indicated: CNP levels were significantly negatively correlated to CGRP levels in patiens with EH and CHD (EH r =0.567, P <0.01, CHD r =0.428, P <0.05).Conclusion Detection of changes of CNP?NO?CGRP and ET contents in blood of patients with EH and CHD provides a valuable laboratory basis for study of its relationship with endothelial cell function and the pathogenesis of dysfunction.
出处 《放射免疫学杂志》 CAS 2001年第5期265-266,共2页 Journal of Radioimmanology
关键词 原发性高血压 冠心病 内皮细胞 血管活性物质 一氧化氮 C-型利钠钛 发病机理 essential hypertension, coronary heart disease, endothelial cell, vasoactive substance
  • 相关文献

参考文献3

  • 1[6]Lgnarro LJ, Buga GM, Wood KS, et al. Endothelium - derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1997;84:9265
  • 2[7]Taddei S, Virdis A, Mattei P, et al. Defective L- Arginine- Nitric Oxide pathway in offspring of essential hypertensive patients. Circulation 1996;94:1298
  • 3[8]Drexler H, Zeiher AM, Meinzer K, et al. Correction of endothelial dysfunction in coronary micrpcireulation of hypercholesterolaemic patients by Larginine. Lancet 1999;338:1546

同被引文献13

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部